Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qiagen (QGEN) Common Equity (2016 - 2025)

Qiagen's Common Equity history spans 17 years, with the latest figure at $3.8 billion for Q4 2025.

  • On a quarterly basis, Common Equity rose 5.91% to $3.8 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $3.8 billion, a 5.91% increase, with the full-year FY2025 number at $3.8 billion, up 5.91% from a year prior.
  • Common Equity hit $3.8 billion in Q4 2025 for Qiagen, up from $3.6 billion in the prior quarter.
  • Over the last five years, Common Equity for QGEN hit a ceiling of $3.8 billion in Q4 2023 and a floor of $2.8 billion in Q1 2021.
  • Historically, Common Equity has averaged $3.4 billion across 5 years, with a median of $3.5 billion in 2022.
  • Biggest five-year swings in Common Equity: rose 14.37% in 2021 and later decreased 6.31% in 2024.
  • Tracing QGEN's Common Equity over 5 years: stood at $3.1 billion in 2021, then rose by 11.95% to $3.5 billion in 2022, then grew by 9.84% to $3.8 billion in 2023, then fell by 6.31% to $3.6 billion in 2024, then grew by 5.91% to $3.8 billion in 2025.
  • Business Quant data shows Common Equity for QGEN at $3.8 billion in Q4 2025, $3.6 billion in Q3 2025, and $3.5 billion in Q2 2025.